Yoshito Komatsu

Pimitespib in patients with advanced gastrointestinal stromal tumor (CHAPTER-GIST-301): a randomized, double-blind, placebo-controlled phase III trial

Yukinori Kurokawa, Yoshitaka Honma, Akira Sawaki et al. · Annals of Oncology · 2022 · 113 citations · Full text

Medicine, Oncology, Pharmacology +13

Phase 2 study of nilotinib as third‐line therapy for patients with gastrointestinal stromal tumor

Akira Sawaki, Toshirou Nishida, Toshihiko Doi et al. · Cancer · 2011 · 85 citations · Full text

Medicine, Oncology, Pharmacotherapy +10

Phase I/II study of sunitinib malate in Japanese patients with gastrointestinal stromal tumor after failure of prior treatment with imatinib mesylate

Kuniaki Shirao, Toshirou Nishida, Toshihiko Doi et al. · Investigational New Drugs · 2009 · 64 citations

Medicine, Oncology, Pharmacotherapy +15

Sunitinib-resistant gastrointestinal stromal tumors harbor cis-mutations in the activation loop of the KIT gene

Toshirou Nishida, Tsuyoshi Takahashi, Akiko Nishitani et al. · International Journal of Clinical Oncology · 2009 · 62 citations

Medicine, Molecular Genetics, Oncology +15

Efficacy and safety of TAS-116, an oral inhibitor of heat shock protein 90, in patients with metastatic or unresectable gastrointestinal stromal tumour refractory to imatinib, sunitinib and regorafenib: a phase II, single-arm trial

Toshihiko Doi, Yukinori Kurokawa, Akira Sawaki et al. · European Journal of Cancer · 2019 · 60 citations · Full text

Medicine, Oncology, Pharmacology +10